2021
DOI: 10.1001/jamapsychiatry.2021.0247
|View full text |Cite
|
Sign up to set email alerts
|

Cost-effectiveness of Treatments for Opioid Use Disorder

Abstract: IMPORTANCE Opioid use disorder (OUD) is a significant cause of morbidity and mortality in the US, yet many individuals with OUD do not receive treatment.OBJECTIVE To assess the cost-effectiveness of OUD treatments and association of these treatments with outcomes in the US.DESIGN AND SETTING This model-based cost-effectiveness analysis included a US population with OUD.INTERVENTIONS Medication-assisted treatment (MAT) with buprenorphine, methadone, or injectable extended-release naltrexone; psychotherapy (beyo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
41
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 71 publications
(42 citation statements)
references
References 73 publications
1
41
0
Order By: Relevance
“…the key and has proved to be cost-effective [12]. Barriers to treatment access should be identified and diminished.…”
Section: Suggested Key Areas Of Prioritiesmentioning
confidence: 99%
See 1 more Smart Citation
“…the key and has proved to be cost-effective [12]. Barriers to treatment access should be identified and diminished.…”
Section: Suggested Key Areas Of Prioritiesmentioning
confidence: 99%
“…The goal should be at least 60–70% or more [11] of the target population in stable long‐term OAT. Widespread access to OAT and harm reduction is probably the key and has proved to be cost‐effective [12]. Barriers to treatment access should be identified and diminished.…”
mentioning
confidence: 99%
“…When MAT is added to a successful therapy-based treatment program with CM, outcomes improve. Treatment for OUD in this study was associated with cost-saving reductions in morbidity and mortality from OUD [38]. Other drug and alcohol problems [39] and co-morbid illnesses are often ignored [40] and undetected without a thorough face-to-face interview, examination, and testing.…”
Section: Transition With Urgency Overdose Reversal To Evaluation Diagnoses and Treat The Whole Patient With Oudmentioning
confidence: 71%
“…When combined with medication for OUD, contingency management demonstrates significant reductions in morbidity and mortality from OUD, considerable cost savings, and reduced hospitalizations and emergency department visits [ 19 , 20 ]. Contingency management is also associated with an overall medium-large effect size ( Cohen d = 0.70) on abstinence from stimulants among patients receiving medication for OUD [ 12 ], which is salient in light of national trends showing accelerated overdoses involving stimulants and high rates of comorbid stimulant misuse with opioids [ 1 , 21 , 22 ].…”
mentioning
confidence: 99%